ZnT3 protein levels are decreased across normal ageing in humans, and further decreased in Alzheimer’s disease postmortem brain tissue [44], together with significant reductions in ZnT3 mRNA levels in disease [45]. Here, SLC30A3 is linked to early-onset autosomal dominant Alzheimer disease.